Data / Form D filings / Telsar Pharma, Inc.
Telsar Pharma, Inc.: Form D filing
Telsar Pharma, Inc., a pharmaceuticals company in Bridgewater, NJ, filed a Form D with the SEC in 2012. The latest, on May 18, 2012, reports $14 million sold of a $14 million offering to 26 investors.
Find out what Telsar Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 520 US HIGHWAY 22, SUITE 201, Bridgewater, NJ, 08807
- Phone
- (908) 895-1200
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1549817
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2012 | New notice | $14,002,500 | $14,002,500 | $0 | 26 | Apr 24, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert L. Desjardins | Executive Officer, Director, Promoter | |
| Christopher L. Del Mastro | Executive Officer | |
| Donna L. Tempel | Executive Officer, Director, Promoter | |
| Jeffrey L. Bird | Director | |
| Arnold L. Oronsky | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of May 14, 2012 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Telsar Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.